Literature DB >> 12414090

Age dependent NMDA contribution to impaired hypotensive cerebral hemodynamics following brain injury.

William M Armstead1.   

Abstract

Previous studies have observed that fluid percussion brain injury (FPI) impaired NMDA induced pial artery dilation (PAD) in an age dependent manner. Unrelated studies observed a similar age dependent impairment of hypotensive cerebral autoregulation after FPI. This study was designed to test the hypothesis that NMDA receptor activation contributes to impairment of cerebral autoregulation during hypotension after FPI in an age dependent manner. Therefore, the role of NMDA in impaired hypotensive cerebrovascular regulation after FPI was compared in newborn and juvenile pigs equipped with a closed cranial window. Ten minutes of hypotension (10-15 ml blood/kg) decreased mean arterial blood pressure uniformly in both groups (approximately 44%). In the newborn, hypotensive PAD was blunted within 1 h of FPI but partially protected by pretreatment with the NMDA antagonist MK801 (1 mg/kg i.v.) (34+/-1 vs. 8+/-1 vs. 25+/-2% for sham control, FPI, and FPI-MK801, respectively). Cerebral blood flow (CBF) was reduced during normotension by FPI, further reduced by hypotension, but both were partially protected by MK801 in the newborn (56+/-5, 35+/-2, and 16+/-1 vs. 62+/-6, 45+/-3, and 30+/-2 ml/min 100 g for normotension, normotension-FPI, and hypotension-FPI in the absence and presence of MK801, respectively). In contrast, blunted hypotensive PAD was protected significantly less by MK801 in the juvenile (32+/-2 vs. 7+/-2 vs. 16+/-2% for sham control, FPI, and FPI-MK801, respectively). Similarly, MK801 had less protective effect on normotensive and hypotensive CBF values post FPI in the juvenile. These data indicate that NMDA receptor activation contributes to impaired hypotensive cerebral hemodynamics following brain injury in an age dependent manner. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414090     DOI: 10.1016/s0165-3806(02)00511-4

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  13 in total

1.  Combination therapy with glucagon and a novel plasminogen activator inhibitor-1-derived peptide enhances protection against impaired cerebrovasodilation during hypotension after traumatic brain injury through inhibition of ERK and JNK MAPK.

Authors:  William M Armstead; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neurol Res       Date:  2012-05-30       Impact factor: 2.448

2.  tPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK.

Authors:  William M Armstead; J Willis Kiessling; John Riley; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Neurol Res       Date:  2011-09       Impact factor: 2.448

3.  Tissue-Type Plasminogen Activator-A296-299 Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor-Dependent Increase in cAMP and p38.

Authors:  William M Armstead; John Riley; Serge Yarovoi; Abd Al-Roof Higazi; Douglas B Cines
Journal:  Stroke       Date:  2016-06-28       Impact factor: 7.914

4.  Neurobehavioral functional deficits following closed head injury in the neonatal pig.

Authors:  Stuart H Friess; Rebecca N Ichord; Kristin Owens; Jill Ralston; Rebecca Rizol; Karen L Overall; Colin Smith; Mark A Helfaer; Susan S Margulies
Journal:  Exp Neurol       Date:  2006-12-15       Impact factor: 5.330

5.  tPA-S481A prevents neurotoxicity of endogenous tPA in traumatic brain injury.

Authors:  William M Armstead; John Riley; Serge Yarovoi; Douglas B Cines; Douglas H Smith; Abd Al-Roof Higazi
Journal:  J Neurotrauma       Date:  2012-04-30       Impact factor: 5.269

6.  Glucagon protects against impaired NMDA-mediated cerebrovasodilation and cerebral autoregulation during hypotension after brain injury by activating cAMP protein kinase A and inhibiting upregulation of tPA.

Authors:  William M Armstead; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  J Neurotrauma       Date:  2011-03-04       Impact factor: 5.269

Review 7.  Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders.

Authors:  William M Armstead; Kumkum Ganguly; J W Kiessling; John Riley; Xiao-Han Chen; Douglas H Smith; Sherman C Stein; Abd A R Higazi; Douglas B Cines; Khalil Bdeir; Sergei Zaitsev; Vladimir R Muzykantov
Journal:  J Neurochem       Date:  2010-04       Impact factor: 5.372

Review 8.  Cerebral blood flow and autoregulation after pediatric traumatic brain injury.

Authors:  Yuthana Udomphorn; William M Armstead; Monica S Vavilala
Journal:  Pediatr Neurol       Date:  2008-04       Impact factor: 3.372

9.  Microparticles Impair Hypotensive Cerebrovasodilation and Cause Hippocampal Neuronal Cell Injury after Traumatic Brain Injury.

Authors:  Leif-Erik Bohman; John Riley; Tatyana N Milovanova; Matthew R Sanborn; Stephen R Thom; William M Armstead
Journal:  J Neurotrauma       Date:  2015-07-31       Impact factor: 5.269

10.  tPA-S(481)A prevents impairment of cerebrovascular autoregulation by endogenous tPA after traumatic brain injury by upregulating p38 MAPK and inhibiting ET-1.

Authors:  William M Armstead; Leif-Erik Bohman; John Riley; Serge Yarovoi; Abd Al-Roof Higazi; Douglas B Cines
Journal:  J Neurotrauma       Date:  2013-08-24       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.